Alkermes (ALKS) EPS (Diluted) (2010 - 2026)
Alkermes' EPS (Diluted) came in at $0.09 for Q3 2026, down 81.2% from $0.49 a year earlier.
Powered by 
Analysis
Alkermes (ALKS) EPS (Diluted) (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Alkermes reported EPS (Diluted) of $0.00; for FY2025, it was $1.43, down 34.0% from FY2024.
- Going back by year, EPS (Diluted) was $2.17 in FY2024 (+3.5%), $2.10 in FY2023, -$0.97 in FY2022 and -$0.30 in FY2021.
- The five-year range for quarterly EPS (Diluted) is -$0.40 (Q1 2026) to $1.38 (Q2 2023).
- Year-over-year, EPS (Diluted) increased in 1 of the last seven quarters, with an average decline of 38.3%.
- The fastest year-over-year change in EPS (Diluted) over five years came in Q3 2024 (growth of 99.1%), and the weakest in Q2 2026 (a decline of 99.4%).
- Business Quant data shows ALKS's EPS (Diluted) at $0.00 (Q2 2026), -$0.40 (Q1 2026) and $0.29 (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 7.22 |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 0.09 |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 2.38 |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 2.04 |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 2.00 |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 7.08 |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 1.94 |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 0.56 |
| 10 | Alkermes | 7.77 Bn | 5.26 Bn | 385.91 Mn | 0.09 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 0.09 |
| Jun 30, 2026 | 0.00 |
| Mar 31, 2026 | -0.40 |
| Dec 31, 2025 | 0.29 |
| Sep 30, 2025 | 0.49 |
| Jun 30, 2025 | 0.52 |
| Mar 31, 2025 | 0.13 |
| Dec 31, 2024 | 0.87 |
| Sep 30, 2024 | 0.55 |
| Jun 30, 2024 | 0.53 |
| Mar 31, 2024 | 0.21 |
| Dec 31, 2023 | 0.66 |
| Sep 30, 2023 | 0.28 |
| Jun 30, 2023 | 1.38 |
| Mar 31, 2023 | -0.25 |
| Dec 31, 2022 | -0.17 |
| Sep 30, 2022 | -0.39 |
| Jun 30, 2022 | -0.18 |
| Mar 31, 2022 | -0.22 |
| Dec 31, 2021 | 0.01 |
API Access
Alkermes EPS (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=eps-diluted&ticker=ALKS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "eps-diluted", "ticker": "ALKS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=eps-diluted&ticker=ALKS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();